Reuters logo
BRIEF-Alimera Sciences and Knight Therapeutics file new drug submission for iluvien in Canada
February 22, 2017 / 1:14 PM / 7 months ago

BRIEF-Alimera Sciences and Knight Therapeutics file new drug submission for iluvien in Canada

Feb 22 (Reuters) - Alimera Sciences Inc

* Alimera Sciences and Knight Therapeutics announce filing of new drug submission for iluvien in Canada

* Alimera Sciences Inc - Knight’s new drug submission (NDS) for iluvien has been accepted for review by Health Canada Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below